BG102870A - Dermatological gels for local therapy in acne vulgaris and herpes simplex - Google Patents

Dermatological gels for local therapy in acne vulgaris and herpes simplex

Info

Publication number
BG102870A
BG102870A BG102870A BG10287098A BG102870A BG 102870 A BG102870 A BG 102870A BG 102870 A BG102870 A BG 102870A BG 10287098 A BG10287098 A BG 10287098A BG 102870 A BG102870 A BG 102870A
Authority
BG
Bulgaria
Prior art keywords
herpes simplex
acne vulgaris
local therapy
dermatological gels
dermatological
Prior art date
Application number
BG102870A
Other languages
Bulgarian (bg)
Other versions
BG63242B1 (en
Inventor
Николай НАЙДЕНОВ
Original Assignee
Николай НАЙДЕНОВ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Николай НАЙДЕНОВ filed Critical Николай НАЙДЕНОВ
Priority to BG102870A priority Critical patent/BG63242B1/en
Priority to AU59633/99A priority patent/AU5963399A/en
Priority to PCT/BG1999/000019 priority patent/WO2000024370A1/en
Publication of BG102870A publication Critical patent/BG102870A/en
Publication of BG63242B1 publication Critical patent/BG63242B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The dermatological gels are used in human medicine. They contain the following components in g.: methenamine (hexamethylenetetramine) from 2.0 to 20.0, polyacrrylic acid 0.1-2.0, isopropanol from 15.0 to 25.0, 5%-soidum hydroxide 0.01-1.0, ethyl alcohol (95o) from 0 to 40.0, aromatizer 0.001-4.0, water from 1.0 to 100.0. 1 claim
BG102870A 1998-10-27 1998-10-27 Dermatological gels for local therapy in acne vulgaris and in herpes simplex BG63242B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BG102870A BG63242B1 (en) 1998-10-27 1998-10-27 Dermatological gels for local therapy in acne vulgaris and in herpes simplex
AU59633/99A AU5963399A (en) 1998-10-27 1999-10-01 Dermatologic gels for the treatment of acne vulgaris and herpes simplex containing methenamine
PCT/BG1999/000019 WO2000024370A1 (en) 1998-10-27 1999-10-01 Dermatologic gels for the treatment of acne vulgaris and herpes simplex containing methenamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG102870A BG63242B1 (en) 1998-10-27 1998-10-27 Dermatological gels for local therapy in acne vulgaris and in herpes simplex

Publications (2)

Publication Number Publication Date
BG102870A true BG102870A (en) 2000-06-30
BG63242B1 BG63242B1 (en) 2001-07-31

Family

ID=3927588

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102870A BG63242B1 (en) 1998-10-27 1998-10-27 Dermatological gels for local therapy in acne vulgaris and in herpes simplex

Country Status (3)

Country Link
AU (1) AU5963399A (en)
BG (1) BG63242B1 (en)
WO (1) WO2000024370A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG1284U1 (en) * 2009-10-19 2010-03-31 Николай НАЙДЕНОВ Dermatological formulation for topical therapy, prophylaxis and cosmetic use
CN111840103B (en) * 2020-08-10 2023-04-07 黑龙江天龙药业有限公司 Long-acting film agent for armpit and preparation method thereof
CN114831924A (en) * 2021-03-17 2022-08-02 武汉恒信源药业有限公司 Urotropine and vaginal local administration preparation of compound thereof and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2356790A1 (en) * 1973-11-14 1975-05-15 Hans Dr Med Voigt Prevention and treatment of herpes infections - by oral or parenteral admin of methenamine
US4456722A (en) * 1982-11-09 1984-06-26 Foley Lary L Composition for control of bacteria and viruses

Also Published As

Publication number Publication date
AU5963399A (en) 2000-05-15
WO2000024370A1 (en) 2000-05-04
BG63242B1 (en) 2001-07-31

Similar Documents

Publication Publication Date Title
AP9801392A0 (en) Concentrated antibody preparation.
MD413G2 (en) Polarized light lamp for biostimulating therapy
ITRM930399A0 (en) USE OF L-CARNITINE OR ACIL L-CARNITINE ESTERS WITH HYDROXY ACIDS TO PRODUCE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES.
NZ338060A (en) Use of bacterial cell wall extract for the manufacture of a medicament for treating a protozoal or parasitic disease
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
MY111718A (en) Deuterated active substances in transdermal application
BG102870A (en) Dermatological gels for local therapy in acne vulgaris and herpes simplex
BG101126A (en) The use of muramylpeptide compounds
IL116733A0 (en) The use of sertraline to treat cancer patients
IL107764A0 (en) Use of certain methanebisphosphonic acid derivatives in fracture healing
ES2006121A6 (en) Method for treating skin diseases
NZ503802A (en) Topical formulation containing delta-aminolevulinic acid
UA42797C2 (en) Quinolone- and naphthyridonecarboxylic acid derivatives and isoindole derivatives for preparation thereof
EP0668771A4 (en) Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs.
MD916G2 (en) Ungent for stomatologic deseases treatment
IT1276040B1 (en) USE OF BENZIDAMINE IN THE TREATMENT OF PATHOLOGICAL STATES CAUSED BY TNF
MX9709979A (en) Retinoids and methods of use of same.
MX9709982A (en) Chalcone retinoids and methods of use of same.
AU4333493A (en) Cutaneous mask for supplying energy to the skin
IT1274592B (en) PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY CONTAINING XENOANTIGENS
SI1196182T1 (en) Method for enhancing production performance in an animal
AU3923695A (en) Use of halogenated beta -carbolines as model substances to produce neurodegenerative disorders
AU3610999A (en) Thiocolchicoside derivative, preparation and therapeutic application
MX9603241A (en) Pharmaceutical products to heal tumor diseases, and process for the preparation thereof.
GEU1998331Y (en) Medicinal Means “Podiura” for External Use